Author

Sarah Watson

Institut Curie - Cited by 2,156 - oncologie - g

Biography

Pharmacist working as a researcher with 10 years of experience in the UMC Research Department. Personal responsibilities include analysis of adverse drug reaction reports for potential signals as well as writing and editing signals shared with the national authorities within the WHO Program for International Drug Monitoring. Also author scientific publications as well as project lead and educate in Pharmacovigilance and Drug Safety in various courses in a global setting.
Title
Cited by
Year
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide …
A Lièvre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ...European Journal of Cancer 141, 62-81, 2020202
130
2020
Targeting the VEGF pathway in osteosarcoma
T Assi, S Watson, B Samra, E Rassy, A Le Cesne, A Italiano, O MirCells 10 (5), 1240, 2021202
22
2021
Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR‐rearranged family
Y Bouchoucha, A Tauziède‐Espariat, A Gauthier, D Guillemot, ...The Journal of Pathology: Clinical Research 8 (3), 217-232, 2022202
10
2022
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
J Vibert, O Saulnier, C Collin, F Petit, KJE Borgman, J Vigneau, M Gautier, ...Molecular Cell 82 (13), 2458-2471. e, 2022202
9
2022
A druggable copper-signalling pathway that drives inflammation
S Solier, S Müller, T Cañeque, A Versini, A Mansart, F Sindikubwabo, ...Nature, 1-9, 2023202
7
2023
Identification of tissue of origin and guided therapeutic applications in cancers of unknown primary using deep learning and RNA sequencing (TransCUPtomics)
J Vibert, G Pierron, C Benoist, N Gruel, D Guillemot, A Vincent-Salomon, ...The Journal of Molecular Diagnostics 23 (10), 1380-1392, 2021202
7
2021
New developments in the pathology and molecular biology of retroperitoneal sarcomas
S Watson, N Gruel, F Le LoarerEuropean Journal of Surgical Oncology, 2022202
6
2022
Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas
S El Zein, L Djeroudi, S Reynaud, D Guillemot, J Masliah‐Planchon, ...Genes, Chromosomes and Cancer 1 (4), 200-205, 2022202
6
2022
The molecular Biology of soft tissue sarcomas: Current knowledge and future perspectives
J Vibert, S WatsonCancers 1 (10), 258, 2022202
4
2022
Percutaneous uterine needle biopsy with microscopic and array-CGH analyses for preoperative sarcoma diagnosis in patients with suspicious myometrial tumors on MRI: a …
J Smadja, S El Zein, G Pierron, S Watson, E Laas, T Ramtohul, D Tzanis, ...Annals of Surgical Oncology 30 (2), 93-953, 2023202
4
2023
Small round cell sarcomas
F Cidre-Aranaz, S Watson, JF Amatruda, T Nakamura, O Delattre, ...Nature Reviews Disease Primers 8 (1), 66, 2022202
4
2022
Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group
M Brahmi, N Gaspar, J Gantzer, M Toulmonde, P Boudou‐Rouquette, ...Cancer Medicine 12 (7), 7801-7807, 2023202
4
2023
1524MO Patterns of care and outcomes of 64 CIC-rearranged sarcoma: A retrospective multicentre case-series within the French Sarcoma Group (FSG)
B Mehdi, N Gaspar, J Gantzer, M Toulmonde, PB Rouquette, E Bompas, ...Annals of Oncology 2, S111, 2021202
3
2021
Nivolumab activity in advanced refractory malignant peritoneal mesothelioma
O Becker, C Beaulaton, J Masliah-Planchon, V Servois, S WatsonEuropean Journal of Cancer 144, 86-88, 2021202
3
2021
1316O Improved nationwide survival of sarcoma patients 10 years after establishment of the NETSARC+ reference center network
JY Blay, A Italiano, N Penel, E Bompas, F Duffaud, CM Chevreau, ...Annals of Oncology 33, S1145-S1146, 0
2
2022
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB AmplificationS Watson, J Cyrta, M Lefevre, JM Planchon, C Louvet, V Servois, ...JCO precision oncology 5, 370-377, 010
2
2021
Desmoid tumors: who, when and how to treat?
R Mikhael, M Smith, D Tzanis, S Watson, AB Miah, S BonvalotCurrent Opinion in Oncology 34 (4), 335-34, 2022202
1
2022
Significant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center
C Di Prata, B Renouf, D Tzanis, T Bouhadiba, S Watson, SE Zein, S Helfre, ...Annals of Surgical Oncology 30 (7), 455-4526, 2023202
1
2023
Neoadjuvant Everolimus for adult giant mesenteric cystic lymphangioma with mTOR pathway activation
S El Zein, N Gruel, S Bonvalot, O Mir, S WatsonThe Oncologist 26 (7), 554-557, 20220
1
2021
Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patients
O Mir, S Watson, C Massard, A Le Cesne, KA Benhadji, JC SoriaAnnals of Oncology 3 (2), 782-784, 2020202
1
2020

Referred From: https://scholar.google.com/citations?user=wfPbiVgAAAAJ&hl=en&oi=sra

Cited by
Citations 2156
h-index 17
i10-index 19
Recommended Journals
Open Access Journals